"Valine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A branched-chain essential amino acid that has stimulant activity. It promotes muscle growth and tissue repair. It is a precursor in the penicillin biosynthetic pathway.
| Descriptor ID |
D014633
|
| MeSH Number(s) |
D12.125.070.950 D12.125.142.930
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Valine".
Below are MeSH descriptors whose meaning is more specific than "Valine".
This graph shows the total number of publications written about "Valine" by people in this website by year, and whether "Valine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Valine" by people in Profiles.
-
A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia. J Clin Psychopharmacol. 2019 Nov/Dec; 39(6):620-627.
-
Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study. J Hepatol. 2019 09; 71(3):486-497.
-
Valbenazine in the treatment of tardive dyskinesia. Neurodegener Dis Manag. 2019 04; 9(2):73-81.
-
Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatment. Contemp Clin Trials. 2017 06; 57:58-68.
-
Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents. Am J Gastroenterol. 2016 06; 111(6):845-51.
-
Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis. JAMA. 2015 May 05; 313(17):1736-44.
-
Prophylactic valacyclovir in a patient with recurrent vestibular disturbances secondary to vestibular neuritis. Am J Otolaryngol. 2012 Jul-Aug; 33(4):487-8.
-
Retinopathy and choroidopathy as the initial signs of hypertensive brainstem encephalopathy. Arch Ophthalmol. 2006 Dec; 124(12):1784-6.
-
VALIANT and EUROPA. Prev Cardiol. 2004; 7(1):42-4.
-
Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A. 1999 Feb 16; 96(4):1609-14.